Search Results 721-730 of 18383 for Lactation

  1. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

    Pregnant or lactating subjects. Apparent/pseudo RHT due to white coat effect, medical inertia, poor therapeutic adherence, or secondary causes of ...

  2. Autologous Muscle Derived Cells for Female Urinary Sphincter Repair - Mayo Clinic

    Patient is pregnant, lactating, or plans to become pregnant during the course of the study. Patient refuses to provide written informed consent. Patient is ...

  3. Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery - Mayo Clinic

    Pregnancy or lactation. Treatment with an investigational drug or participation in an interventional study within 30 days prior to administration of study ...

  4. Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid - Mayo Clinic

    ... lactating; Known history of human immunodeficiency virus (HIV) infection; Medical conditions that may cause non-hepatic increases in ALP (e.g., Paget's ...

  5. Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant - Mayo Clinic

    Participation eligibility · Pregnant women · Nursing women (lactating females are eligible provided that they agree not to breast feed while taking lenalidomide) ...

  6. A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant - Mayo Clinic

    Female participants who are lactating and breastfeeding or have a positive serum pregnancy test during the Screening period. Major surgery within 14 days ...

  7. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    Pregnant or nursing (lactating) women. Treatment with the following therapies within the specified time period: Monoclonal antibodies (anti-CD38 and anti ...

  8. Evaluation of the AMICUS Extracorporeal Photopheresis (ECP) System in Patients with Chronic Graft Versus Host Disease - Mayo Clinic

    Females who are pregnant and/or lactating. Subjects with aphakia. Subjects with a history of a light-sensitive disease state including, but not limited to ...

  9. A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis - Mayo Clinic

    - Prior treatment with a BET inhibitor. - Pregnant or lactating women - Any other concurrent severe and/or uncontrolled concomitant medical condition that

  10. A Study to Evaluate Parsaclisib (INCB050465), Rituximab, Cyclophosphamide, Doxorubicin, Vincristine And Prednisone (Par-CHOP) Immunochemotherapy for Patients with Newly Diagnosed High Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Nursing persons (lactating persons are eligibile provided that they aree not to breast feel while taking parscaclisib);; Persons of childbearing potential ...